AIBT AIBOTICS, INC.

OTC Medicinal Chemicals & Botanical Products NV CIK: 0001763329
AI RATING
STRONG_SELL
95% Confidence

Investment Thesis

Aibotics is a non-viable business with catastrophic financial deterioration and zero operational momentum. The company generated only $2.2K in revenue while burning $1.6M in net losses and $371.6K in operating cash outflows, indicating no viable revenue model or path to profitability. With negative stockholders' equity of -$3.9M, liabilities exceeding assets by 4.8x, and a current ratio of 0.05x, the company faces imminent insolvency and is operationally insolvent.

Strengths

  • + Positive gross margin at 100% on minimal revenue indicates products sold generate full margins

Risks

  • ! Negative stockholders equity of -$3.9M indicates technical insolvency
  • ! Revenue of only $2.2K with operating losses of $1.4M demonstrates no viable business model
  • ! Current ratio of 0.05x with liabilities 4.8x assets indicates acute liquidity crisis and default risk
  • ! Negative operating cash flow of -$371.6K with zero capex indicates cash burn with no reinvestment
  • ! ROA of -158.1% and operating margin of -62,776% show severe operational dysfunction
  • ! No insider activity in 90 days suggests loss of management confidence
  • ! Cash position of $230.5K insufficient to cover monthly burn rate

Key Metrics to Watch

Financial Metrics

Revenue
2.2K
Net Income
-1.6M
EPS (Diluted)
$0.00
Free Cash Flow
-371.6K
Total Assets
1.0M
Cash
230.5K

Profitability Ratios

Gross Margin 100.0%
Operating Margin -62,776.4%
Net Margin -73,635.7%
ROE N/A
ROA -158.1%
FCF Margin -17,024.1%

Balance Sheet & Liquidity

Current Ratio
0.05x
Quick Ratio
0.05x
Debt/Equity
N/A
Debt/Assets
482.1%
Interest Coverage
-8.24x
Long-term Debt
N/A
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-03-19T17:41:48.877096 | Data as of: 2025-09-30 | Powered by Claude AI